Drugmakers face weaker won

Published: 2009-04-14 06:57:00

Updated: 2009-04-14 06:57:00

It is a challenging time for leading domestic pharmaceutical firms – Dong-A Pharm, Yuhan Corporation and Daewoong Pharm - to cope with the won's weakness against major currencies.

“The hike of raw material prices and the fall in the value of the Korean currency eroded the revenues of these com...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK